for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Johnson & Johnson

JNJ.N

Latest Trade

163.62USD

Change

-0.22(-0.13%)

Volume

1,831,202

Today's Range

163.29

 - 

164.03

52 Week Range

134.83

 - 

173.62

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
163.84
Open
163.71
Volume
1,831,202
3M AVG Volume
151.18
Today's High
164.03
Today's Low
163.29
52 Week High
173.62
52 Week Low
134.83
Shares Out (MIL)
2,633.40
Market Cap (MIL)
426,557.50
Forward P/E
17.01
Dividend (Yield %)
2.62

Next Event

Johnson & Johnson ESG Investor Update

Latest Developments

更多

U.S. CDC Says Administered 318,576,441 Doses Of Covid-19 Vaccine As Of June 21 Versus 317,966,408 Doses Administered As Of June 20

U.S. CDC Says Delivered 379,003,410 Doses Of Covid-19 Vaccine As Of June 19 Versus 377,935,390 Doses Delivered As Of June 18

U.S. CDC Says Delivered 377.9 Million Doses Of Covid-19 Vaccine As Of June 18

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Industry

Biotechnology & Drugs

Contact Info

1 Johnson And Johnson Plz

NEW BRUNSWICK, NJ

08933-0001

United States

+1.732.5242455

https://www.jnj.com/

Executive Leadership

Alex Gorsky

Chairman of the Board, Chief Executive Officer

Paulus A. Stoffels

Vice Chairman- Executive Committee, Chief Scientific Officer

Joaquin Boix Duato

Vice Chairman - Executive Committee

Joseph J. Wolk

Chief Financial Officer, Executive Vice President

Peter M. Fasolo

Chief Human Resource Officer, Executive Vice President

Key Stats

1.95 mean rating - 20 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

81.6K

2019

82.1K

2020

82.6K

2021(E)

91.3K
EPS (USD)

2018

8.180

2019

8.680

2020

8.030

2021(E)

9.523
Price To Earnings (TTM)
28.61
Price To Sales (TTM)
5.07
Price To Book (MRQ)
6.48
Price To Cash Flow (TTM)
18.96
Total Debt To Equity (MRQ)
51.06
LT Debt To Equity (MRQ)
45.97
Return on Investment (TTM)
11.95
Return on Equity (TTM)
9.23

Latest News

Latest News

UPDATE 5-EU says J&J to miss vaccine supply target in second quarter

* J&J had committed to delivering 55m doses to EU by end of June

EU says J&J to miss vaccine supply target in second quarter

Johnson & Johnson is expected to miss its COVID-19 vaccine supply target to the European Union for the second quarter after about 20 million doses were banned for use out of precaution over safety concerns, a EU Commission spokesman said.

UPDATE 2-J&J to send S.Africa more than 300,000 vaccine doses, says Aspen

* Aspen targets steady flow of supply from July (Adds detail from interview with Aspen CEO)

UPDATE 1-Germany demands that J&J make up COVID-19 vaccine gap in July

Germany's health ministry said Johnson & Johnson must deliver 6.5 million COVID-19 vaccine doses to Germany in July to make up for a shortfall expected in June after the U.S. Food & Drug Administration (FDA) told the company to dispose of millions of doses because of contamination...

South African health inspectors will not release unsuitable J&J vaccines

South African health inspectors on Sunday said they will not release Johnson & Johnson COVID-19 vaccines that may have been contaminated during production at a U.S. plant.

Germany demands that J&J make up COVID-19 vaccine gap in July

Germany's health ministry on Sunday said Johnson & Johnson must deliver 6.5 million COVID-19 vaccine doses to Germany in July to make up for a shortfall expected in June after the U.S. Food & Drug Administration (FDA) told the company to dispose of millions of doses because...

UPDATE 6-U.S. FDA asks J&J to discard millions of COVID-19 vaccine doses

The U.S. Food & Drug Administration on Friday said Johnson & Johnson must throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use.

EU does not expect J&J will meet end of June vaccine target

The European Union does not expect Johnson & Johnson will be able to deliver 55 million COVID-19 vaccine doses it had committed to shipping to the bloc by the end of June, an EU official said on Friday.

FDA asks Johnson & Johnson to discard 60 mln vaccine doses made at Baltimore plant: NYT

The U.S. Food & Drug Administration has asked Johnson & Johnson to discard 60 million doses of its COVID-19 vaccine that were manufactured at the troubled Baltimore factory, the New York Times reported on Friday, citing people familiar with the matter. (Reporting by Mrinalika...

UPDATE 1-EU won't use J&J COVID shots from time of U.S. contamination issue

Europe's drug regulator said on Friday batches of Johnson & Johnson's COVID-19 vaccine made for the region around the time when contamination issues were revealed at a U.S. manufacturing site would, as a precaution, not be used.

FOCUS-J&J vaccine drive stalls out in U.S after safety pause

Safety concerns about Johnson & Johnson's COVID-19 vaccine along with overall flagging demand for vaccinations have slowed its U.S. rollout to a crawl, leaving close to half of the 21 million doses produced for the United States sitting unused.

UPDATE 1-EMA highlights guidance not to use heparin for COVID-19 vaccine-linked clots

The European Medicines Agency (EMA) on Monday pushed guidance for doctors not to use the blood thinner heparin to treat rare blood clots and low blood platelets in people who got AstraZeneca's or Johnson & Johnson's COVID-19 shots.

EMA highlights guidance not to use heparin for COVID-19 vaccine-linked clots

The European Medicines Agency (EMA) on Monday highlighted guidance for doctors which calls for them to avoid heparin when treating rare blood clots and low platelet counts in patients who received AstraZeneca's or Johnson & Johnson's COVID-19 vaccines.

Johnson & Johnson talking to Taiwan about providing COVID-19 vaccine

Johnson & Johnson said on Friday that it has been in talks with Taiwan about providing its COVID-19 vaccine to the island since last year.

AstraZeneca in talks to shift COVID-19 vaccine production to Catalent factory - NYT

AstraZeneca Plc is in talks with the U.S. government to shift production of its COVID-19 vaccine from a Baltimore plant to a factory owned by Catalent Inc , the New York Times reported on Wednesday, citing people familiar with the matter.

UPDATE 4-U.S. Supreme Court rebuffs J&J appeal over $2 billion baby powder judgment

The U.S. Supreme Court on Tuesday declined to hear Johnson & Johnson's bid to overturn a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in the company's baby powder and other talc products.

CORRECTED-UPDATE 2-U.S. Supreme Court rebuffs J&J appeal over $2 billion baby powder judgment

The U.S. Supreme Court on Tuesday declined to hear Johnson & Johnson's bid to overturn a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in the company's baby powder and other talc products.

U.S. Supreme Court declines to hear J&J appeal over $2 billion baby powder judgment

The U.S. Supreme Court on Monday declined to hear Johnson & Johnson's bid to overturn a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in the company's baby powder and other talc products.

UPDATE 2-Foxconn, founder Gou apply to purchase BioNTech vaccines for Taiwan

Foxconn and its billionaire founder Terry Gou sought permission from Taiwan's government on Tuesday to buy COVID-19 vaccines from Germany's BioNTech SE after the island was hit with a rise in infections.

UPDATE 1-South Korea says J&J's COVID-19 shots fully taken up

South Korea closed its first phase of reservations for Johnson and Johnson COVID-19 vaccines on Tuesday as military personnel signed up for all 800,000 shots on offer, the government said.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up